1
|
Kessi M, Chen B, Pan L, Yang L, Yang L, Peng J, He F, Yin F. Disruption of mitochondrial and lysosomal functions by human CACNA1C variants expressed in HEK 293 and CHO cells. Front Mol Neurosci 2023; 16:1209760. [PMID: 37448958 PMCID: PMC10336228 DOI: 10.3389/fnmol.2023.1209760] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2023] [Accepted: 05/30/2023] [Indexed: 07/18/2023] Open
Abstract
Objective To investigate the pathogenesis of three novel de novo CACNA1C variants (p.E411D, p.V622G, and p.A272V) in causing neurodevelopmental disorders and arrhythmia. Methods Several molecular experiments were carried out on transfected human embryonic kidney 293 (HEK 293) and Chinese hamster ovary (CHO) cells to explore the effects of p.E411D, p.V622G, and p.A272V variants on electrophysiology, mitochondrial and lysosomal functions. Electrophysiological studies, RT-qPCR, western blot, apoptosis assay, mito-tracker fluorescence intensity, lyso-tracker fluorescence intensity, mitochondrial calcium concentration test, and cell viability assay were performed. Besides, reactive oxygen species (ROS) levels, ATP levels, mitochondrial copy numbers, mitochondrial complex I, II, and cytochrome c functions were measured. Results The p.E411D variant was found in a patient with attention deficit-hyperactive disorder (ADHD), and moderate intellectual disability (ID). This mutant demonstrated reduced calcium current density, mRNA, and protein expression, and it was localized in the nucleus, cytoplasm, lysosome, and mitochondria. It exhibited an accelerated apoptosis rate, impaired autophagy, and mitophagy. It also demonstrated compromised mitochondrial cytochrome c oxidase, complex I, and II enzymes, abnormal mitochondrial copy numbers, low ATP levels, abnormal mitochondria fluorescence intensity, impaired mitochondrial fusion and fission, and elevated mitochondrial calcium ions. The p.V622G variant was identified in a patient who presented with West syndrome and moderate global developmental delay. The p.A272V variant was found in a patient who presented with epilepsy and mild ID. Both mutants (p.V622G and p.A272V) exhibited reduced calcium current densities, decreased mRNA and protein expressions, and they were localized in the nucleus, cytoplasm, lysosome, and mitochondria. They exhibited accelerated apoptosis and proliferation rates, impaired autophagy, and mitophagy. They also exhibited abnormal mitochondrial cytochrome c oxidase, complex I and II enzymes, abnormal mitochondrial copy numbers, low ATP, high ROS levels, abnormal mitochondria fluorescence intensity, impaired mitochondrial fusion and fission, as well as elevated mitochondrial calcium ions. Conclusion The p.E411D, p.V622G and p.A272V mutations of human CACNA1C reduce the expression level of CACNA1C proteins, and impair mitochondrial and lysosomal functions. These effects induced by CACNA1C variants may contribute to the pathogenesis of CACNA1C-related disorders.
Collapse
Affiliation(s)
- Miriam Kessi
- Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, China
- Hunan Intellectual and Developmental Disabilities Research Center, Changsha, China
- Clinical Research Center for Children Neurodevelopmental Disabilities of Hunan Province, Xiangya Hospital, Central South University, Changsha, China
| | - Baiyu Chen
- Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, China
- Hunan Intellectual and Developmental Disabilities Research Center, Changsha, China
- Clinical Research Center for Children Neurodevelopmental Disabilities of Hunan Province, Xiangya Hospital, Central South University, Changsha, China
| | - Langui Pan
- Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, China
- Hunan Intellectual and Developmental Disabilities Research Center, Changsha, China
- Clinical Research Center for Children Neurodevelopmental Disabilities of Hunan Province, Xiangya Hospital, Central South University, Changsha, China
| | - Li Yang
- Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, China
- Hunan Intellectual and Developmental Disabilities Research Center, Changsha, China
- Clinical Research Center for Children Neurodevelopmental Disabilities of Hunan Province, Xiangya Hospital, Central South University, Changsha, China
| | - Lifen Yang
- Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, China
- Hunan Intellectual and Developmental Disabilities Research Center, Changsha, China
- Clinical Research Center for Children Neurodevelopmental Disabilities of Hunan Province, Xiangya Hospital, Central South University, Changsha, China
| | - Jing Peng
- Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, China
- Hunan Intellectual and Developmental Disabilities Research Center, Changsha, China
- Clinical Research Center for Children Neurodevelopmental Disabilities of Hunan Province, Xiangya Hospital, Central South University, Changsha, China
| | - Fang He
- Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, China
- Hunan Intellectual and Developmental Disabilities Research Center, Changsha, China
- Clinical Research Center for Children Neurodevelopmental Disabilities of Hunan Province, Xiangya Hospital, Central South University, Changsha, China
| | - Fei Yin
- Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, China
- Hunan Intellectual and Developmental Disabilities Research Center, Changsha, China
- Clinical Research Center for Children Neurodevelopmental Disabilities of Hunan Province, Xiangya Hospital, Central South University, Changsha, China
| |
Collapse
|
2
|
Liu J, Li X, Xu N, Han H, Li X. Role of ion channels in the mechanism of proteinuria (Review). Exp Ther Med 2022; 25:27. [PMID: 36561615 PMCID: PMC9748662 DOI: 10.3892/etm.2022.11726] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2022] [Accepted: 10/10/2022] [Indexed: 11/25/2022] Open
Abstract
Proteinuria is a common clinical manifestation of kidney diseases, such as glomerulonephritis, nephrotic syndrome, immunoglobulin A nephropathy and diabetic nephropathy. Therefore, proteinuria is considered to be a risk factor for renal dysfunction. Furthermore, proteinuria is also significantly associated with the progression of kidney diseases and increased mortality. Its occurrence is closely associated with damage to the structure of the glomerular filtration membrane. An impaired glomerular filtration membrane can affect the selective filtration function of the kidneys; therefore, several macromolecular substances, such as proteins, may pass through the filtration membrane and promote the manifestation of proteinuria. It has been reported that ion channels play a significant role in the mechanisms underlying proteinuria. Ion channel mutations or other dysfunctions have been implicated in several diseases, therefore ion channels could be used as major therapeutic targets. The mechanisms underlying the action of ion channels and ion transporters in proteinuria have been overlooked in the literature, despite their importance in identifying novel targets for treating proteinuria and delaying the progression of kidney diseases. The current review article focused on the four key ion channel groups, namely Na+, Ca2+, Cl- and K+ ion channels and the associated ion transporters.
Collapse
Affiliation(s)
- Jie Liu
- Department of Nephrology, Affiliated Hospital of Weifang Medical University, Weifang, Shandong 261000, P.R. China
| | - Xuewei Li
- Department of Rheumatology, Affiliated Hospital of Weifang Medical University, Weifang, Shandong 261000, P.R. China
| | - Ning Xu
- Department of Nephrology, Affiliated Hospital of Weifang Medical University, Weifang, Shandong 261000, P.R. China
| | - Huirong Han
- Department of Anesthesiology, Weifang Medical University, Weifang, Shandong 261000, P.R. China
| | - Xiangling Li
- Department of Nephrology, Affiliated Hospital of Weifang Medical University, Weifang, Shandong 261000, P.R. China,Correspondence to: Professor Xiangling Li, Department of Nephrology, Affiliated Hospital of Weifang Medical University, 2428 Yu He Road, Weifang, Shandong 261000, P.R. China
| |
Collapse
|
3
|
Ménard C, Charnet P, Rousset M, Vignes M, Cens T. Cav2.1 C-terminal fragments produced in Xenopus laevis oocytes do not modify the channel expression and functional properties. Eur J Neurosci 2020; 51:1900-1913. [PMID: 31981388 DOI: 10.1111/ejn.14685] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2019] [Revised: 01/10/2020] [Accepted: 01/17/2020] [Indexed: 12/01/2022]
Abstract
The sequence and genomic organization of the CACNA1A gene that encodes the Cav2.1 subunit of both P and Q-type Ca2+ channels are well conserved in mammals. In human, rat and mouse CACNA1A, the use of an alternative acceptor site at the exon 46-47 boundary results in the expression of a long Cav2.1 splice variant. In transfected cells, the long isoform of human Cav2.1 produces a C-terminal fragment, but it is not known whether this fragment affects Cav2.1 expression or functional properties. Here, we cloned the long isoform of rat Cav2.1 (Cav2.1(e47)) and identified a novel variant with a shorter C-terminus (Cav2.1(e47s)) that differs from those previously described in the rat and mouse. When expressed in Xenopus laevis oocytes, Cav2.1(e47) and Cav2.1(e47s) displayed similar functional properties as the short isoform (Cav2.1). We show that Cav2.1 isoforms produced short (CT1) and long (CT1(e47)) C-terminal fragments that interacted in vivo with the auxiliary Cavβ4a subunit. Overexpression of the C-terminal fragments did not affect Cav2.1 expression and functional properties. Furthermore, the functional properties of a Cav2.1 mutant without the C-terminal Cavβ4 binding domain (Cav2.1ΔCT2) were similar to those of Cav2.1 and were not influenced by the co-expression of the missing fragments (CT2 or CT2(e47)). Our results exclude a functional role of the C-terminal fragments in Cav2.1 biophysical properties in an expression system widely used to study this channel.
Collapse
Affiliation(s)
- Claudine Ménard
- Institut des Biomolécules Max Mousseron (IBMM), Montpellier, France.,IBMM, Université de Montpellier, Montpellier, France
| | - Pierre Charnet
- Institut des Biomolécules Max Mousseron (IBMM), Montpellier, France.,IBMM, Université de Montpellier, Montpellier, France
| | - Matthieu Rousset
- Institut des Biomolécules Max Mousseron (IBMM), Montpellier, France.,IBMM, Université de Montpellier, Montpellier, France
| | - Michel Vignes
- Institut des Biomolécules Max Mousseron (IBMM), Montpellier, France.,IBMM, Université de Montpellier, Montpellier, France
| | - Thierry Cens
- Institut des Biomolécules Max Mousseron (IBMM), Montpellier, France.,IBMM, Université de Montpellier, Montpellier, France
| |
Collapse
|
4
|
Snidal CA, Li Q, Elliott BB, Mah HKH, Chen RHC, Gardezi SR, Stanley EF. Molecular Characterization of an SV Capture Site in the Mid-Region of the Presynaptic CaV2.1 Calcium Channel C-Terminal. Front Cell Neurosci 2018; 12:127. [PMID: 29867360 PMCID: PMC5958201 DOI: 10.3389/fncel.2018.00127] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2017] [Accepted: 04/23/2018] [Indexed: 01/28/2023] Open
Abstract
Neurotransmitter is released from presynaptic nerve terminals at fast-transmitting synapses by the action potential-gating of voltage dependent calcium channels (CaV), primarily of the CaV2.1 and CaV2.2 types. Entering Ca2+ diffuses to a nearby calcium sensor associated with a docked synaptic vesicle (SV) and initiates its fusion and discharge. Our previous findings that single CaVs can gate SV fusion argued for one or more tethers linking CaVs to docked SVs but the molecular nature of these tethers have not been established. We recently developed a cell-free, in vitro biochemical assay, termed SV pull-down (SV-PD), to test for SV binding proteins and used this to demonstrate that CaV2.2 or the distal third of its C-terminal can capture SVs. In subsequent reports we identified the binding site and characterized an SV binding motif. In this study, we set out to test if a similar SV-binding mechanism exists in the primary presynaptic channel type, CaV2.1. We cloned the chick variant of this channel and to our surprise found that it lacked the terminal third of the C-terminal, ruling out direct correlation with CaV2.2. We used SV-PD to identify an SV binding site in the distal half of the CaV2.1 C-terminal, a region that corresponds to the central third of the CaV2.2 C-terminal. Mutant fusion proteins combined with motif-blocking peptide strategies identified two domains that could account for SV binding; one in an alternatively spliced region (E44) and a second more distal site. Our findings provide a molecular basis for CaV2.1 SV binding that can account for recent evidence of C-terminal-dependent transmitter release modulation and that may contribute to SV tethering within the CaV2.1 single channel Ca2+ domain.
Collapse
Affiliation(s)
- Christine A Snidal
- Presynaptic Mechanisms Laboratory, Krembil Research Institute, University Health Network, Toronto, ON, Canada
| | - Qi Li
- Presynaptic Mechanisms Laboratory, Krembil Research Institute, University Health Network, Toronto, ON, Canada
| | - Brittany B Elliott
- Presynaptic Mechanisms Laboratory, Krembil Research Institute, University Health Network, Toronto, ON, Canada
| | - Henry K-H Mah
- Presynaptic Mechanisms Laboratory, Krembil Research Institute, University Health Network, Toronto, ON, Canada
| | - Robert H C Chen
- Presynaptic Mechanisms Laboratory, Krembil Research Institute, University Health Network, Toronto, ON, Canada
| | - Sabiha R Gardezi
- Presynaptic Mechanisms Laboratory, Krembil Research Institute, University Health Network, Toronto, ON, Canada
| | - Elise F Stanley
- Presynaptic Mechanisms Laboratory, Krembil Research Institute, University Health Network, Toronto, ON, Canada
| |
Collapse
|
5
|
Aikawa T, Watanabe T, Miyazaki T, Mikuni T, Wakamori M, Sakurai M, Aizawa H, Ishizu N, Watanabe M, Kano M, Mizusawa H, Watase K. Alternative splicing in the C-terminal tail of Cav2.1 is essential for preventing a neurological disease in mice. Hum Mol Genet 2018; 26:3094-3104. [PMID: 28510727 DOI: 10.1093/hmg/ddx193] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2016] [Accepted: 05/09/2017] [Indexed: 12/13/2022] Open
Abstract
Alternative splicing (AS) that occurs at the final coding exon (exon 47) of the Cav2.1 voltage-gated calcium channel (VGCC) gene produces two major isoforms in the brain, MPI and MPc. These isoforms differ in their splice acceptor sites; human MPI is translated into a polyglutamine tract associated with spinocerebellar ataxia type 6 (SCA6), whereas MPc splices to an immediate stop codon, resulting in a shorter cytoplasmic tail. To gain insight into the functional role of the AS in vivo and whether modulating the splice patterns at this locus can be a potential therapeutic strategy for SCA6, here we created knockin mice that exclusively express MPc by inserting the splice-site mutation. The resultant Cacna1aCtmKO/CtmKO mice developed non-progressive neurological phenotypes, featuring early-onset ataxia and absence seizure without significant alterations in the basic properties of the channel. Interactions of Cav2.1 with Cavβ4 and Rimbp2 were significantly reduced while those with GABAB2 were enhanced in the cerebellum of Cacna1aCtmKO/CtmKO mice. Treatment with the GABAB antagonist CGP35348 partially rescued the motor impairments seen in Cacna1aCtmKO/CtmKO mice. These results suggest that the carboxyl-terminal domain of Cav2.1 is not essential for maintaining the basic properties of the channel in the cerebellar Purkinje neurons but is involved in multiple interactions of Cav2.1 with other proteins, and plays an essential role in preventing a complex neurological disease.
Collapse
Affiliation(s)
- Tomonori Aikawa
- Center for Brain Integration Research, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.,Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology (JST), Tokyo 102-8666, Japan
| | - Takaki Watanabe
- Department of Neurophysiology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan
| | - Taisuke Miyazaki
- Department of Anatomy, Hokkaido University School of Medicine, Sapporo, Japan
| | - Takayasu Mikuni
- Department of Neurophysiology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.,Max Planck Florida Institute for Neuroscience, Max Planck Way Jupiter, FL 33458, USA
| | - Minoru Wakamori
- Department of Oral Biology, Graduate School of Dentistry, Tohoku University, Sendai 980-8575, Japan
| | - Miyano Sakurai
- Center for Brain Integration Research, Tokyo Medical and Dental University, Tokyo 113-8510, Japan
| | - Hidenori Aizawa
- Laboratory of Molecular Neuroscience, Medical Research Institute, Tokyo Medical and Dental University, Tokyo 113-8510, Japan
| | - Nobutaka Ishizu
- Department of Neurology, Tokyo National Hospital, Tokyo, Japan
| | - Masahiko Watanabe
- Department of Anatomy, Hokkaido University School of Medicine, Sapporo, Japan
| | - Masanobu Kano
- Department of Neurophysiology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan
| | - Hidehiro Mizusawa
- Center for Brain Integration Research, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.,Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology (JST), Tokyo 102-8666, Japan.,Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.,National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan
| | - Kei Watase
- Center for Brain Integration Research, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.,Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology (JST), Tokyo 102-8666, Japan
| |
Collapse
|
6
|
Hirano M, Takada Y, Wong CF, Yamaguchi K, Kotani H, Kurokawa T, Mori MX, Snutch TP, Ronjat M, De Waard M, Mori Y. C-terminal splice variants of P/Q-type Ca 2+ channel Ca V2.1 α 1 subunits are differentially regulated by Rab3-interacting molecule proteins. J Biol Chem 2017; 292:9365-9381. [PMID: 28377503 DOI: 10.1074/jbc.m117.778829] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2017] [Revised: 03/26/2017] [Indexed: 11/06/2022] Open
Abstract
Voltage-dependent Ca2+ channels (VDCCs) mediate neurotransmitter release controlled by presynaptic proteins such as the scaffolding proteins Rab3-interacting molecules (RIMs). RIMs confer sustained activity and anchoring of synaptic vesicles to the VDCCs. Multiple sites on the VDCC α1 and β subunits have been reported to mediate the RIMs-VDCC interaction, but their significance is unclear. Because alternative splicing of exons 44 and 47 in the P/Q-type VDCC α1 subunit CaV2.1 gene generates major variants of the CaV2.1 C-terminal region, known for associating with presynaptic proteins, we focused here on the protein regions encoded by these two exons. Co-immunoprecipitation experiments indicated that the C-terminal domain (CTD) encoded by CaV2.1 exons 40-47 interacts with the α-RIMs, RIM1α and RIM2α, and this interaction was abolished by alternative splicing that deletes the protein regions encoded by exons 44 and 47. Electrophysiological characterization of VDCC currents revealed that the suppressive effect of RIM2α on voltage-dependent inactivation (VDI) was stronger than that of RIM1α for the CaV2.1 variant containing the region encoded by exons 44 and 47. Importantly, in the CaV2.1 variant in which exons 44 and 47 were deleted, strong RIM2α-mediated VDI suppression was attenuated to a level comparable with that of RIM1α-mediated VDI suppression, which was unaffected by the exclusion of exons 44 and 47. Studies of deletion mutants of the exon 47 region identified 17 amino acid residues on the C-terminal side of a polyglutamine stretch as being essential for the potentiated VDI suppression characteristic of RIM2α. These results suggest that the interactions of the CaV2.1 CTD with RIMs enable CaV2.1 proteins to distinguish α-RIM isoforms in VDI suppression of P/Q-type VDCC currents.
Collapse
Affiliation(s)
- Mitsuru Hirano
- From the Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, and
| | - Yoshinori Takada
- From the Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, and
| | - Chee Fah Wong
- From the Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, and.,the Department of Biology, Faculty of Science and Mathematics, Universiti Pendidikan Sultan Idris, 35900 Tanjung Malim, Perak, Malaysia
| | - Kazuma Yamaguchi
- From the Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, and
| | - Hiroshi Kotani
- From the Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, and
| | - Tatsuki Kurokawa
- From the Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, and
| | - Masayuki X Mori
- From the Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, and
| | - Terrance P Snutch
- the Michael Smith Laboratories and Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada, and
| | - Michel Ronjat
- the LabEx Ion Channels, Science and Therapeutics, INSERM UMR1087/CNRS UMR6291, Institut du Thorax, Université de Nantes, Nantes F-44000, France
| | - Michel De Waard
- the LabEx Ion Channels, Science and Therapeutics, INSERM UMR1087/CNRS UMR6291, Institut du Thorax, Université de Nantes, Nantes F-44000, France
| | - Yasuo Mori
- From the Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, and .,the Department of Technology and Ecology, Hall of Global Environmental Studies, Kyoto University, Kyoto 615-8510, Japan
| |
Collapse
|
7
|
Soga K, Ishikawa K, Furuya T, Iida T, Yamada T, Ando N, Ota K, Kanno-Okada H, Tanaka S, Shintaku M, Eishi Y, Mizusawa H, Yokota T. Gene dosage effect in spinocerebellar ataxia type 6 homozygotes: A clinical and neuropathological study. J Neurol Sci 2016; 373:321-328. [PMID: 28131213 DOI: 10.1016/j.jns.2016.12.051] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2016] [Revised: 12/20/2016] [Accepted: 12/23/2016] [Indexed: 02/07/2023]
Abstract
Spinocerebellar ataxia type 6 (SCA6) is an autosomal dominant neurodegenerative disorder. However, it remains unclear whether SCA6 shows a gene dosage effect, defined by earlier age-of-onset in homozygotes than heterozygotes. Herein, we retrospectively analyzed four homozygous SCA6 subjects from our single institution cohort of 120 SCA6 subjects. We also performed a neuropathological investigation into an SCA6 individual with compound heterozygous expansions. In the 116 heterozygotes, there was an inverse correlation of age-of-onset with the number of CAG repeats in the expanded allele, and with the total number of CAG repeats, in both normal and expanded alleles. The age-of-onset in the four homozygotes was within the 95% confidence interval of the age-of-onset versus the repeat-lengths correlations determined in the 116 heterozygotes. Nevertheless, all homozygotes had earlier onset than their parents, and showed rapid disease progression. Neuropathology revealed neuronal loss, as well as α1A-calcium channel protein aggregates in Purkinje cells, a few α1A-calcium channel protein aggregates in the neocortex and basal ganglia, and neuronal loss in Clarke's column and the globus pallidus not seen in heterozygotes. These data suggest a mild clinical and neuropathological gene dosage effect in SCA6 subjects.
Collapse
Affiliation(s)
- Kazumasa Soga
- Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan
| | - Kinya Ishikawa
- Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan; The Center for Personalized Medicine for Healthy Aging, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.
| | - Tokuro Furuya
- Department of Neurology, Kawaguchi Kogyo General Hospital, 1-18-15 Aoki, Kawaguchi, Saitama 332-0031, Japan
| | - Tadatsune Iida
- Department of Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan; Department of Cellular Neurobiology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
| | - Tetsuo Yamada
- Department of Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan; Laboratory of Pathology, Department of Clinical Laboratory Medicine, Bunkyo Gakuin University Graduate School of Health Care Science, 2-4-1 Mukogaoka, Bunkyo-ku, Tokyo 113-0023, Japan
| | - Noboru Ando
- Department of Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan
| | - Kiyobumi Ota
- Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan
| | - Hiromi Kanno-Okada
- Department of Cancer Pathology, Hokkaido University Graduate School of Medicine, North 15, West 7, Kita-ku, Sapporo 060-8638, Hokkaido, Japan; Department of Surgical Pathology, Hokkaido University Hospital, Hokkaido University, North 14, West 5, Kita-ku, Sapporo 060-8648, Hokkaido, Japan
| | - Shinya Tanaka
- Department of Cancer Pathology, Hokkaido University Graduate School of Medicine, North 15, West 7, Kita-ku, Sapporo 060-8638, Hokkaido, Japan
| | - Masayuki Shintaku
- Department of Pathology, Shiga Medical Center for Adults, 5-4-30 Moriyama, Moriyama, Shiga 524-8524, Japan
| | - Yoshinobu Eishi
- Department of Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan
| | - Hidehiro Mizusawa
- Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan; The National Center Hospital, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira, Tokyo 187-8551, Japan
| | - Takanori Yokota
- Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan
| |
Collapse
|
8
|
|
9
|
Figiel M, Krzyzosiak WJ, Switonski PM, Szlachcic WJ. Mouse Models of SCA3 and Other Polyglutamine Repeat Ataxias. Mov Disord 2015. [DOI: 10.1016/b978-0-12-405195-9.00064-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
10
|
Kalia J, Milescu M, Salvatierra J, Wagner J, Klint JK, King GF, Olivera BM, Bosmans F. From foe to friend: using animal toxins to investigate ion channel function. J Mol Biol 2014; 427:158-175. [PMID: 25088688 DOI: 10.1016/j.jmb.2014.07.027] [Citation(s) in RCA: 125] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2014] [Revised: 07/18/2014] [Accepted: 07/18/2014] [Indexed: 12/19/2022]
Abstract
Ion channels are vital contributors to cellular communication in a wide range of organisms, a distinct feature that renders this ubiquitous family of membrane-spanning proteins a prime target for toxins found in animal venom. For many years, the unique properties of these naturally occurring molecules have enabled researchers to probe the structural and functional features of ion channels and to define their physiological roles in normal and diseased tissues. To illustrate their considerable impact on the ion channel field, this review will highlight fundamental insights into toxin-channel interactions and recently developed toxin screening methods and practical applications of engineered toxins.
Collapse
Affiliation(s)
- Jeet Kalia
- Indian Institute of Science Education and Research Pune; Pune, Maharashtra 411 008 India
| | - Mirela Milescu
- Division of Biological Sciences; University of Missouri, Columbia, MO 65211 USA
| | - Juan Salvatierra
- Department of Physiology; Johns Hopkins University, School of Medicine, Baltimore, MD 21205 USA
| | - Jordan Wagner
- Department of Physiology; Johns Hopkins University, School of Medicine, Baltimore, MD 21205 USA
| | - Julie K Klint
- Institute for Molecular Bioscience; The University of Queensland, St. Lucia, QLD 4072 Australia
| | - Glenn F King
- Institute for Molecular Bioscience; The University of Queensland, St. Lucia, QLD 4072 Australia
| | | | - Frank Bosmans
- Department of Physiology; Johns Hopkins University, School of Medicine, Baltimore, MD 21205 USA.,Solomon H. Snyder Department of Neuroscience; Johns Hopkins University, School of Medicine, Baltimore, MD 21205 USA
| |
Collapse
|
11
|
Hermann D, Mezler M, Müller MK, Wicke K, Gross G, Draguhn A, Bruehl C, Nimmrich V. Synthetic Aβ oligomers (Aβ(1-42) globulomer) modulate presynaptic calcium currents: prevention of Aβ-induced synaptic deficits by calcium channel blockers. Eur J Pharmacol 2013; 702:44-55. [PMID: 23376566 DOI: 10.1016/j.ejphar.2013.01.030] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2012] [Revised: 01/14/2013] [Accepted: 01/16/2013] [Indexed: 10/27/2022]
Abstract
Alzheimer's disease is accompanied by increased brain levels of soluble amyloid-β (Aβ) oligomers. It has been suggested that oligomers directly impair synaptic function, thereby causing cognitive deficits in Alzheimer's disease patients. Recently, it has been shown that synthetic Aβ oligomers directly modulate P/Q-type calcium channels, possibly leading to excitotoxic cascades and subsequent synaptic decline. Using whole-cell recordings we studied the modulation of recombinant presynaptic calcium channels in HEK293 cells after application of a stable Aβ oligomer preparation (Aβ1-42 globulomer). Aβ globulomer shifted the half-activation voltage of P/Q-type and N-type calcium channels to more hyperpolarized values (by 11.5 and 7.5 mV). Application of non-aggregated Aβ peptides had no effect. We then analyzed the potential of calcium channel blockers to prevent Aβ globulomer-induced synaptic decline in hippocampal slice cultures. Specific block of P/Q-type or N-type calcium channels with peptide toxins completely reversed Aβ globulomer-induced deficits in glutamatergic neurotransmission. Two state-dependent low molecular weight P/Q-type and N-type calcium channel blockers also protected neurons from Aβ-induced alterations. On the contrary, inhibition of L-type calcium channels failed to reverse the deficit. Our data show that Aβ globulomer directly modulates recombinant P/Q-type and N-type calcium channels in HEK293 cells. Block of presynaptic calcium channels with both state-dependent and state-independent modulators can reverse Aβ-induced functional deficits in synaptic transmission. These findings indicate that presynaptic calcium channel blockers may be a therapeutic strategy for the treatment of Alzheimer's disease.
Collapse
Affiliation(s)
- David Hermann
- Neuroscience Research, GPRD, Abbott, 67061 Ludwigshafen, Germany
| | | | | | | | | | | | | | | |
Collapse
|
12
|
Development of Purkinje cell degeneration in a knockin mouse model reveals lysosomal involvement in the pathogenesis of SCA6. Proc Natl Acad Sci U S A 2012; 109:17693-8. [PMID: 23054835 DOI: 10.1073/pnas.1212786109] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
Spinocerebellar ataxia type 6 (SCA6) is a neurodegenerative disease caused by the expansion of a polyglutamine tract in the Ca(v)2.1 voltage-gated calcium channel. To elucidate how the expanded polyglutamine tract in this plasma membrane protein causes the disease, we created a unique knockin mouse model that modestly overexpressed the mutant transcripts under the control of an endogenous promoter (MPI-118Q). MPI-118Q mice faithfully recapitulated many features of SCA6, including selective Purkinje cell degeneration. Surprisingly, analysis of inclusion formation in the mutant Purkinje cells indicated the lysosomal localization of accumulated mutant Ca(v)2.1 channels in the absence of autophagic response. The lack of cathepsin B, a major lysosomal cysteine proteinase, exacerbated the loss of Purkinje cells and was accompanied by an acceleration of inclusion formation in this model. Thus, the pathogenic mechanism of SCA6 involves the endolysosomal degradation pathway, and unique pathological features of this model further illustrate the pivotal role of protein context in the pathogenesis of polyglutamine diseases.
Collapse
|
13
|
Mezler M, Barghorn S, Schoemaker H, Gross G, Nimmrich V. A β-amyloid oligomer directly modulates P/Q-type calcium currents in Xenopus oocytes. Br J Pharmacol 2012; 165:1572-83. [PMID: 21883149 DOI: 10.1111/j.1476-5381.2011.01646.x] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Abstract
BACKGROUND AND PURPOSE β-amyloid (Aβ) oligomers have been implicated in the early pathophysiology of Alzheimer's disease (AD). While the precise nature of the molecular target has not been fully revealed, a number of studies have indicated that Aβ oligomers modulate neuron-specific ion channels. We recently provided evidence that Aβ oligomers suppress isolated P/Q-type calcium currents in cultured nerve cells. Using a heterologous expression system, we aimed to prove a direct effect on the membrane channel mediating such current. EXPERIMENTAL APPROACH The effects of a synthetically generated Aβ oligomer, Aβ globulomer, were investigated on P/Q-type currents recorded from Xenopus laevis oocytes expressing the full P/Q-type calcium channel or the pore-forming subunit only. We also examined the effects of Aβ globulomer on recombinant NMDA receptor currents. Finally, we compared the modulation by Aβ globulomer with that induced by a synthetic monomeric Aβ. KEY RESULTS Aβ globulomer directly and dose-dependently modulated P/Q-type calcium channels. A leftward shift of the current-voltage curve indicated that the threshold for channel opening was reduced. The effect of Aβ globulomer was also present when only the α1A subunit of the normally tripartite channel was expressed. In contrast, the monomeric Aβ had no effect on P/Q current. Also globulomer Aβ had no effect on glutamate-induced NMDA currents. CONCLUSIONS AND IMPLICATIONS The α1A subunit of the P/Q-type calcium channel is directly modulated by oligomeric Aβ. Threshold reduction as well as an increase in current at synaptic terminals may facilitate vesicle release and could trigger excitotoxic events in the brains of patients with AD.
Collapse
Affiliation(s)
- M Mezler
- Neuroscience Research, GPRD, Abbott, Ludwigshafen, Germany.
| | | | | | | | | |
Collapse
|
14
|
Huang H, Tan BZ, Shen Y, Tao J, Jiang F, Sung YY, Ng CK, Raida M, Köhr G, Higuchi M, Fatemi-Shariatpanahi H, Harden B, Yue DT, Soong TW. RNA editing of the IQ domain in Ca(v)1.3 channels modulates their Ca²⁺-dependent inactivation. Neuron 2012; 73:304-16. [PMID: 22284185 DOI: 10.1016/j.neuron.2011.11.022] [Citation(s) in RCA: 98] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/29/2011] [Indexed: 11/29/2022]
Abstract
Adenosine-to-inosine RNA editing is crucial for generating molecular diversity, and serves to regulate protein function through recoding of genomic information. Here, we discover editing within Ca(v)1.3 Ca²⁺ channels, renown for low-voltage Ca²⁺-influx and neuronal pacemaking. Significantly, editing occurs within the channel's IQ domain, a calmodulin-binding site mediating inhibitory Ca²⁺-feedback (CDI) on channels. The editing turns out to require RNA adenosine deaminase ADAR2, whose variable activity could underlie a spatially diverse pattern of Ca(v)1.3 editing seen across the brain. Edited Ca(v)1.3 protein is detected both in brain tissue and within the surface membrane of primary neurons. Functionally, edited Ca(v)1.3 channels exhibit strong reduction of CDI; in particular, neurons within the suprachiasmatic nucleus show diminished CDI, with higher frequencies of repetitive action-potential and calcium-spike activity, in wild-type versus ADAR2 knockout mice. Our study reveals a mechanism for fine-tuning Ca(v)1.3 channel properties in CNS, which likely impacts a broad spectrum of neurobiological functions.
Collapse
Affiliation(s)
- Hua Huang
- Department of Physiology, Yong Loo Lin School Medicine, National University of Singapore, 117597 Singapore
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Rajakulendran S, Kaski D, Hanna MG. Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS. Nat Rev Neurol 2012; 8:86-96. [PMID: 22249839 DOI: 10.1038/nrneurol.2011.228] [Citation(s) in RCA: 96] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
The past two decades have witnessed the emergence of a new and expanding field of neurological diseases--the genetic ion channelopathies. These disorders arise from mutations in genes that encode ion channel subunits, and manifest as paroxysmal attacks involving the brain or spinal cord, and/or muscle. The voltage-gated P/Q-type calcium channel (P/Q channel) is highly expressed in the cerebellum, hippocampus and cortex of the mammalian brain. The P/Q channel has a fundamental role in mediating fast synaptic transmission at central and peripheral nerve terminals. Autosomal dominant mutations in the CACNA1A gene, which encodes voltage-gated P/Q-type calcium channel subunit α(1) (the principal pore-forming subunit of the P/Q channel) are associated with episodic and progressive forms of cerebellar ataxia, familial hemiplegic migraine, vertigo and epilepsy. This Review considers, from both a clinical and genetic perspective, the various neurological phenotypes arising from inherited P/Q channel dysfunction, with a focus on recent advances in the understanding of the pathogenetic mechanisms underlying these disorders.
Collapse
Affiliation(s)
- Sanjeev Rajakulendran
- Medical Research Council Center for Neuromuscular Diseases, Box 102, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK
| | | | | |
Collapse
|
16
|
Abstract
Voltage-gated calcium channels (VGCC) play obligatory physiological roles, including modulation of neuronal: functions, synaptic plasticity, neurotransmitter release and gene transcription. Dysregulation and maladaptive changes in VGCC expression and activities may occur in the sensory pathway under various pathological conditions that could contribute to the development of pain. In this review, we summarized the most recent findings on the regulation of VGCC expression and physiological functions in the sensory pathway, and in dysregulation and maladaptive changes of VGCC under pain-inducing conditions. The implications of: these changes in understanding the mechanisms of pain transduction and in new drug design are also discussed.
Collapse
Affiliation(s)
- John Park
- Department of Pharmacology, University of California-Irvine School of Medicine, Irvine, CA, USA
| | | |
Collapse
|
17
|
The carboxy-terminal fragment of alpha(1A) calcium channel preferentially aggregates in the cytoplasm of human spinocerebellar ataxia type 6 Purkinje cells. Acta Neuropathol 2010; 119:447-64. [PMID: 20043227 PMCID: PMC2841749 DOI: 10.1007/s00401-009-0630-0] [Citation(s) in RCA: 41] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2009] [Revised: 12/18/2009] [Accepted: 12/18/2009] [Indexed: 11/29/2022]
Abstract
Spinocerebellar ataxia type 6 (SCA6) is an autosomal dominant neurodegenerative disease caused by a small polyglutamine (polyQ) expansion (control: 4–20Q; SCA6: 20–33Q) in the carboxyl(C)-terminal cytoplasmic domain of the α1A voltage-dependent calcium channel (Cav2.1). Although a 75–85-kDa Cav2.1 C-terminal fragment (CTF) is toxic in cultured cells, its existence in human brains and its role in SCA6 pathogenesis remains unknown. Here, we investigated whether the small polyQ expansion alters the expression pattern and intracellular distribution of Cav2.1 in human SCA6 brains. New antibodies against the Cav2.1 C-terminus were used in immunoblotting and immunohistochemistry. In the cerebella of six control individuals, the CTF was detected in sucrose- and SDS-soluble cytosolic fractions; in the cerebella of two SCA6 patients, it was additionally detected in SDS-insoluble cytosolic and sucrose-soluble nuclear fractions. In contrast, however, the CTF was not detected either in the nuclear fraction or in the SDS-insoluble cytosolic fraction of SCA6 extracerebellar tissues, indicating that the CTF being insoluble in the cytoplasm or mislocalized to the nucleus only in the SCA6 cerebellum. Immunohistochemistry revealed abundant aggregates in cell bodies and dendrites of SCA6 Purkinje cells (seven patients) but not in controls (n = 6). Recombinant CTF with a small polyQ expansion (rCTF-Q28) aggregated in cultured PC12 cells, but neither rCTF-Q13 (normal-length polyQ) nor full-length Cav2.1 with Q28 did. We conclude that SCA6 pathogenesis may be associated with the CTF, normally found in the cytoplasm, being aggregated in the cytoplasm and additionally distributed in the nucleus.
Collapse
|
18
|
Rajakulendran S, Schorge S, Kullmann DM, Hanna MG. Dysfunction of the Ca(V)2.1 calcium channel in cerebellar ataxias. F1000 BIOLOGY REPORTS 2010; 2. [PMID: 20948794 PMCID: PMC2948357 DOI: 10.3410/b2-4] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Mutations in the CACNA1A gene are associated with episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6). CACNA1A encodes the α-subunit of the P/Q-type calcium channel or CaV2.1, which is highly enriched in the cerebellum. It is one of the main channels linked to synaptic transmission throughout the human central nervous system. Here, we compare recent advances in the understanding of the genetic changes that underlie EA2 and SCA6 and what these new findings suggest about the mechanism of the disease.
Collapse
Affiliation(s)
- Sanjeev Rajakulendran
- MRC Centre for Neuromuscular Diseases, Institute of Neurology, University College London Queen Square, London WC1N 3BG UK
| | | | | | | |
Collapse
|
19
|
Kreiner L, Christel CJ, Benveniste M, Schwaller B, Lee A. Compensatory regulation of Cav2.1 Ca2+ channels in cerebellar Purkinje neurons lacking parvalbumin and calbindin D-28k. J Neurophysiol 2009; 103:371-81. [PMID: 19906882 DOI: 10.1152/jn.00635.2009] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Ca(v)2.1 channels regulate Ca(2+) signaling and excitability of cerebellar Purkinje neurons. These channels undergo a dual feedback regulation by incoming Ca(2+) ions, Ca(2+)-dependent facilitation and inactivation. Endogenous Ca(2+)-buffering proteins, such as parvalbumin (PV) and calbindin D-28k (CB), are highly expressed in Purkinje neurons and therefore may influence Ca(v)2.1 regulation by Ca(2+). To test this, we compared Ca(v)2.1 properties in dissociated Purkinje neurons from wild-type (WT) mice and those lacking both PV and CB (PV/CB(-/-)). Unexpectedly, P-type currents in WT and PV/CB(-/-) neurons differed in a way that was inconsistent with a role of PV and CB in acute modulation of Ca(2+) feedback to Ca(v)2.1. Ca(v)2.1 currents in PV/CB(-/-) neurons exhibited increased voltage-dependent inactivation, which could be traced to decreased expression of the auxiliary Ca(v)beta(2a) subunit compared with WT neurons. Although Ca(v)2.1 channels are required for normal pacemaking of Purkinje neurons, spontaneous action potentials were not different in WT and PV/CB(-/-) neurons. Increased inactivation due to molecular switching of Ca(v)2.1 beta-subunits may preserve normal activity-dependent Ca(2+) signals in the absence of Ca(2+)-buffering proteins in PV/CB(-/-) Purkinje neurons.
Collapse
Affiliation(s)
- Lisa Kreiner
- Department of Molecular Physiology and Biophysics, University of Iowa, 51 Newton Road, Iowa City, IA 52242, USA
| | | | | | | | | |
Collapse
|
20
|
Tsunemi T, Ishikawa K, Jin H, Mizusawa H. Cell-type-specific alternative splicing in spinocerebellar ataxia type 6. Neurosci Lett 2008; 447:78-81. [PMID: 18835329 DOI: 10.1016/j.neulet.2008.09.065] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2008] [Revised: 09/17/2008] [Accepted: 09/17/2008] [Indexed: 10/21/2022]
Abstract
The alpha1A voltage-dependent calcium-channel (Ca(v)2.1) gene, the causative gene for spinocerebellar ataxia type 6 (SCA6), is transcribed into two major mRNA isoforms by alternative splicing at the intron 46-exon 47 boundary. One isoform has a stop codon upstream of the CAG repeat. The other "toxic isoform" has an alternatively spliced 5-nucleotide (GGCAG) insertion at the beginning of exon 47. This insertion leads to disruption of the following stop codon and transcription of a polyglutamine-encoding Ca(v)2.1 mRNA. The aim of our study is to investigate whether the expanded CAG repeat of exon 47 in Ca(v)2.1 gene increases the relative amount of the toxic isoform in Purkinje cells. Purkinje and granule cells were independently isolated in brain from subjects with SCA6 and quantified the amount of the toxic isoform mRNA by using real-time reverse transcription (RT)-PCR. We designed two sets of probe and primers: Set A for assessing total Ca(v)2.1 mRNA, and Set B for assessing the toxic isoform mRNA. The ratio of total Ca(v)2.1 mRNA to G3PDH mRNA was similar between Purkinje and granule cells in brain from both normal controls and patients with SCA6, and the ratio of toxic isoform mRNA to total Ca(v)2.1 mRNA did not differ between Purkinje and granule cells in control brains. However, this ratio was increased in Purkinje cells but not in granule cells in SCA6 brains. Our results suggest that toxic isoform mRNA is increased in a Purkinje cell-specific manner, which may result in SCA6-associated selective neurodegeneration.
Collapse
Affiliation(s)
- Taiji Tsunemi
- Department of Neurology and Neurological Science, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan.
| | | | | | | |
Collapse
|
21
|
Spinocerebellar ataxia type 6 knockin mice develop a progressive neuronal dysfunction with age-dependent accumulation of mutant CaV2.1 channels. Proc Natl Acad Sci U S A 2008; 105:11987-92. [PMID: 18687887 DOI: 10.1073/pnas.0804350105] [Citation(s) in RCA: 119] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
Spinocerebellar ataxia type 6 (SCA6) is a neurodegenerative disorder caused by CAG repeat expansions within the voltage-gated calcium (Ca(V)) 2.1 channel gene. It remains controversial whether the mutation exerts neurotoxicity by changing the function of Ca(V)2.1 channel or through a gain-of-function mechanism associated with accumulation of the expanded polyglutamine protein. We generated three strains of knockin (KI) mice carrying normal, expanded, or hyperexpanded CAG repeat tracts in the Cacna1a locus. The mice expressing hyperexpanded polyglutamine (Sca6(84Q)) developed progressive motor impairment and aggregation of mutant Ca(V)2.1 channels. Electrophysiological analysis of cerebellar Purkinje cells revealed similar Ca(2+) channel current density among the three KI models. Neither voltage sensitivity of activation nor inactivation was altered in the Sca6(84Q) neurons, suggesting that expanded CAG repeat per se does not affect the intrinsic electrophysiological properties of the channels. The pathogenesis of SCA6 is apparently linked to an age-dependent process accompanied by accumulation of mutant Ca(V)2.1 channels.
Collapse
|
22
|
Cens T, Leyris JP, Charnet P. Introduction into Cav2.1 of the homologous mutation of Cav1.2 causing the Timothy syndrome questions the role of V421 in the phenotypic definition of P-type Ca2+ channel. Pflugers Arch 2008; 457:417-30. [DOI: 10.1007/s00424-008-0534-1] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2008] [Revised: 04/17/2008] [Accepted: 05/15/2008] [Indexed: 01/06/2023]
|
23
|
Su X, Leon LA, Laping NJ. Role of Spinal Cav2.2 and Cav2.1 Ion Channels in Bladder Nociception. J Urol 2008; 179:2464-9. [DOI: 10.1016/j.juro.2008.01.088] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2007] [Indexed: 10/22/2022]
Affiliation(s)
- Xin Su
- Department of Urology, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania
| | - Lisa A. Leon
- Department of Urology, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania
| | - Nicholas J. Laping
- Department of Urology, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania
| |
Collapse
|
24
|
Rajapaksha WRAKJS, Wang D, Davies JN, Chen L, Zamponi GW, Fisher TE. Novel splice variants of rat CaV2.1 that lack much of the synaptic protein interaction site are expressed in neuroendocrine cells. J Biol Chem 2008; 283:15997-6003. [PMID: 18390553 DOI: 10.1074/jbc.m710544200] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Voltage-gated Ca(2+) channels are responsible for the activation of the Ca(2+) influx that triggers exocytotic secretion. The synaptic protein interaction (synprint) site found in the II-III loop of Ca(V)2.1 and Ca(V)2.2 mediates a physical association with synaptic proteins that may be crucial for fast neurotransmission and axonal targeting. We report here the use of nested PCR to identify two novel splice variants of rat Ca(V)2.1 that lack much of the synprint site. Furthermore, we compare immunofluorescence data derived from antibodies directed against sequences in the Ca(V)2.1 synprint site and carboxyl terminus to show that channel variants lacking a portion of the synprint site are expressed in two types of neuroendocrine cells. Immunofluorescence data also suggest that such variants are properly targeted to neuroendocrine terminals. When expressed in a mammalian cell line, both splice variants yielded Ca(2+) currents, but the variant containing the larger of the two deletions displayed a reduced current density and a marked shift in the voltage dependence of inactivation. These results have important implications for Ca(V)2.1 function and for the mechanisms of Ca(V)2.1 targeting in neurons and neuroendocrine cells.
Collapse
|
25
|
Richards KS, Swensen AM, Lipscombe D, Bommert K. Novel CaV2.1 clone replicates many properties of Purkinje cell CaV2.1 current. Eur J Neurosci 2008; 26:2950-61. [PMID: 18001290 DOI: 10.1111/j.1460-9568.2007.05912.x] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
The P-type calcium current is mediated by a voltage-sensing CaV2.1 alpha subunit in combination with modulatory auxiliary subunits. In Purkinje neurones, this current has distinctively slow inactivation kinetics that may depend on alternative splicing of the alpha subunit and/or association with different CaVbeta subunits. To better understand the molecular components of P-type calcium current, we cloned a CaV2.1 cDNA from total mouse brain. The full-length CaV2.1 isoform that we isolated (GenBank AY714490) contains sequences recently shown to be present in Purkinje neurones. In agreement with previously published work, the alternatively spliced amino acid V421, implicated in slow inactivation, was not encoded in AY714490 and was absent from reverse transcription-polymerase chain reaction products generated from single Purkinje cells. Next, we studied the expression of the four known mouse auxiliary CaVbeta2 isoforms in Purkinje neurones. Confirmation of the presence of CaVbeta2a in Purkinje cells, previously shown by others to slow CaV2.1 kinetics, led us to characterize its influence on current dynamics. We studied currents generated by the clone AY714490 coexpressed in tsA201 cells with four different CaVbeta subunits. In addition to the well-documented slowing of open-state inactivation kinetics, coexpression with the CaVbeta2a subunit also protected CaV2.1 channels from closed-state inactivation and prevented the channel from inactivating during physiological trains of action potential-like stimuli. This strong resistance to inactivation parallels the property of Purkinje neurone P-type currents and is suggestive of a role for CaVbeta2a in modulating the inactivation properties of P-type calcium currents in Purkinje neurones.
Collapse
|
26
|
Tanaka K, Shirakawa H, Okada K, Konno M, Nakagawa T, Serikawa T, Kaneko S. Increased Ca2+ channel currents in cerebellar Purkinje cells of the ataxic groggy rat. Neurosci Lett 2007; 426:75-80. [PMID: 17884288 DOI: 10.1016/j.neulet.2007.08.046] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2007] [Revised: 08/09/2007] [Accepted: 08/22/2007] [Indexed: 11/23/2022]
Abstract
The ataxic groggy rat (strain name; GRY) is an autosomal recessive neurological mutant found in a closed colony of Slc:Wistar rats. Recent genetic analysis has identified the missense (M251K) mutation in the alpha(1) subunit of the Ca(V)2.1 (P/Q-type) voltage-dependent Ca(2+) channel gene (Cacna1a) of GRY rat. In this study, we found that high-voltage-activated (HVA) Ca(2+) channel currents in acutely dissociated Purkinje cells of GRY rats showed increased (not decreased) current density and depolarizing shift of the activation and inactivation curves compared with those of normal Wistar rats. In contrast low-voltage-activated (LVA) Ca(2+) channel currents of GRY rats showed no significant changes. These results suggest that functional alteration of Ca(2+) channel currents in cerebellar Purkinje cells of GRY rats is attributed to the change of HVA Ca(2+) channel currents, and that increased HVA Ca(2+) channel function underlies the cerebellar dysfunction and ataxic phenotype of GRY rats.
Collapse
Affiliation(s)
- Kenta Tanaka
- Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida-shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan
| | | | | | | | | | | | | |
Collapse
|
27
|
Chang SY, Yong TF, Yu CY, Liang MC, Pletnikova O, Troncoso JC, Burgunder JM, Soong TW. Age and gender-dependent alternative splicing of P/Q-type calcium channel EF-hand. Neuroscience 2007; 145:1026-36. [PMID: 17291689 PMCID: PMC1978091 DOI: 10.1016/j.neuroscience.2006.12.054] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2006] [Revised: 12/23/2006] [Accepted: 12/28/2006] [Indexed: 11/25/2022]
Abstract
Ca(v)2.1 Ca(2+) channels (P/Q-type), which participate in various key roles in the CNS by mediating calcium influx, are extensively spliced. One of its alternatively-spliced exons is 37, which forms part of the EF hand. The expression of exon 37a (EFa form), but not exon 37b (EFb form), confers the channel an activity-dependent enhancement of channel opening known as Ca(2+)-dependent facilitation (CDF). In this study, we analyzed the trend of EF hand splice variant distributions in mouse, rat and human brain tissues. We observed a developmental switch in rodents, as well as an age and gender bias in human brain tissues, suggestive of a possible role of these EF hand splice variants in neurophysiological specialization. A parallel study performed on rodent brains showed that the data drawn from human and rodent tissues may not necessarily correlate in the process of aging.
Collapse
Affiliation(s)
- Siao Yun Chang
- Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 2 Medical Drive, Singapore 117597
| | - Tan Fong Yong
- Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 2 Medical Drive, Singapore 117597
| | - Chye Yun Yu
- National Neuroscience Institute, 11 Jalan Tan Tock Seng, Singapore 308433
| | - Mui Cheng Liang
- Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 2 Medical Drive, Singapore 117597
| | - Olga Pletnikova
- Departments of Pathology and Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
| | - Juan C. Troncoso
- Departments of Pathology and Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
| | | | - Tuck Wah Soong
- Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 2 Medical Drive, Singapore 117597
- National Neuroscience Institute, 11 Jalan Tan Tock Seng, Singapore 308433
- Department Biomedical Engineering, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
| |
Collapse
|
28
|
Saegusa H, Wakamori M, Matsuda Y, Wang J, Mori Y, Zong S, Tanabe T. Properties of human Cav2.1 channel with a spinocerebellar ataxia type 6 mutation expressed in Purkinje cells. Mol Cell Neurosci 2007; 34:261-70. [PMID: 17188510 DOI: 10.1016/j.mcn.2006.11.006] [Citation(s) in RCA: 55] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2006] [Revised: 10/15/2006] [Accepted: 11/10/2006] [Indexed: 11/18/2022] Open
Abstract
Spinocerebellar ataxia type 6 (SCA6) is caused by polyglutamine expansion in P/Q-type Ca2+ channels (Ca(v)2.1) and is characterized by predominant degeneration of cerebellar Purkinje cells. To characterize the Ca(v)2.1 channel with an SCA6 mutation in cerebellar Purkinje cells, we have generated knock-in mouse models that express human Ca(v)2.1 with 28 polyglutamine repeats (disease range) and with 13 polyglutamine repeats (normal range). Patch-clamp recordings of the Purkinje cells from homozygous control or SCA6 knock-in mice revealed a non-inactivating current that is highly sensitive to a spider toxin omega-Agatoxin IVA, indicating that the human Ca(v)2.1 expressed in Purkinje cells exhibits typical P-type properties in contrast to the previous data showing Q-type properties, when it was expressed in cultured cell lines. Furthermore, the voltage dependence of activation and inactivation and current density were not different between SCA6 and control, though these properties were altered in previous reports using non-neuronal cells as expression systems. Therefore, our results do not support the notion that the alteration of the channel properties may underlie the pathogenic mechanism of SCA6.
Collapse
Affiliation(s)
- Hironao Saegusa
- Department of Pharmacology and Neurobiology, Graduate School of Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima, Tokyo 113-8519, Japan
| | | | | | | | | | | | | |
Collapse
|
29
|
Tringham EW, Payne CE, Dupere JRB, Usowicz MM. Maturation of rat cerebellar Purkinje cells reveals an atypical Ca2+ channel current that is inhibited by omega-agatoxin IVA and the dihydropyridine (-)-(S)-Bay K8644. J Physiol 2006; 578:693-714. [PMID: 17124267 PMCID: PMC2151333 DOI: 10.1113/jphysiol.2006.121905] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023] Open
Abstract
To determine if the properties of Ca2+ channels in cerebellar Purkinje cells change during postnatal development, we recorded Ca2+ channel currents from Purkinje cells in cerebellar slices of mature (postnatal days (P) 40-50) and immature (P13-20) rats. We found that at P40-50, the somatic Ca2+ channel current was inhibited by omega-agatoxin IVA at concentrations selective for P-type Ca2+ channels (approximately 85%; IC50, <1 nM) and by the dihydropyridine (-)-(S)-Bay K8644 (approximately 70%; IC50, approximately 40 nM). (-)-(S)-Bay K8644 is known to activate L-type Ca2+ channels, but the decrease in current was not secondary to the activation of L-type channels because inhibition by (-)-(S)-Bay K8644 persisted in the presence of the L-type channel blocker (R,S)-nimodipine. By contrast, at P13-20, the current was inhibited by omega-agatoxin IVA (approximately 86%; IC50, approximately 1 nM) and a minor component was inhibited by (R,S)-nimodipine (approximately 8%). The dihydropyridine (-)-(S)-Bay K8644 had no clear effect when applied alone, but in the presence of (R,S)-nimodipine it reduced the current (approximately 40%), suggesting that activation of L-type channels by (-)-(S)-Bay K8644 masks its inhibition of non-L-type channels. Our findings indicate that Purkinje neurons express a previously unrecognized type of Ca2+ channel that is inhibited by omega-agatoxin IVA, like prototypical P-type channels, and by (-)-(S)-Bay K8644, unlike classical P-type or L-type channels. During maturation, there is a decrease in the size of the L-type current and an increase in the size of the atypical Ca2+ channel current. These changes may contribute to the maturation of the electrical properties of Purkinje cells.
Collapse
Affiliation(s)
- Elizabeth W Tringham
- Department of Pharmacology, University of Bristol, University Walk, Bristol BS8 1TD, UK
| | | | | | | |
Collapse
|
30
|
Yamazaki K, Shigetomi E, Ikeda R, Nishida M, Kiyonaka S, Mori Y, Kato F. Blocker-resistant presynaptic voltage-dependent Ca2+ channels underlying glutamate release in mice nucleus tractus solitarii. Brain Res 2006; 1104:103-13. [PMID: 16814754 DOI: 10.1016/j.brainres.2006.05.077] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2006] [Revised: 05/20/2006] [Accepted: 05/24/2006] [Indexed: 11/17/2022]
Abstract
The visceral sensory information from the internal organs is conveyed via the vagus and glossopharyngeal primary afferent fibers and transmitted to the second-order neurons in the nucleus of the solitary tract (NTS). The glutamate release from the solitary tract (TS) axons to the second-order NTS neurons remains even in the presence of toxins that block N- and P/Q-type voltage-dependent Ca(2+) channels (VDCCs). The presynaptic VDCC playing the major role at this synapse remains unidentified. To address this issue, we examined two hypotheses in this study. First, we examined whether the remaining large component occurs through activation of a omega-conotoxin GVIA (omega-CgTX)-insensitive variant of N-type VDCC by using the mice genetically lacking its pore-forming subunit alpha(1B). Second, we examined whether R-type VDCCs are involved in transmitter release at the TS-NTS synapse. The EPSCs evoked by stimulation of the TS were recorded in medullary slices from young mice. omega-Agatoxin IVA (omega-AgaIVA; 200 nM) did not significantly affect the EPSC amplitude in the mice genetically lacking N-type VDCC. SNX-482 (500 nM) and Ni(2+) (100 microM) did not significantly reduce EPSC amplitude in ICR mice. These results indicate that, unlike in most of the brain synapses identified to date, the largest part of the glutamate release at the TS-NTS synapse in mice occurs through activation of non-L, non-P/Q, non-R, non-T and non-N (including its posttranslational variants) VDCCs at least according to their pharmacological properties identified to date.
Collapse
Affiliation(s)
- Koji Yamazaki
- Laboratory of Neurophysiology, Department of Neuroscience,The Jikei University School of Medicine, 3-25-8 Nishi-shimbashi, Minato, Tokyo 105-8461, Japan
| | | | | | | | | | | | | |
Collapse
|
31
|
Andrés-Mateos E, Cruces J, Renart J, Solís-Garrido LM, Serantes R, de Lucas-Cerrillo AM, Montiel C. Bovine CACNA1A gene and comparative analysis of the CAG repeats associated to human spinocerebellar ataxia type-6. Gene 2006; 380:54-61. [PMID: 16876337 DOI: 10.1016/j.gene.2006.06.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2006] [Revised: 05/31/2006] [Accepted: 06/02/2006] [Indexed: 12/13/2022]
Abstract
A small expansion of a CAG repeat domain in exon 47 of the human CACNA1A gene, which codes for the pore-forming alpha1A subunit of P/Q-type Ca2+ channels, causes spinocerebellar ataxia type-6. Only the human alpha1A protein has been demonstrated to contain the poly(Q) tract, although this locus has also recently been detected in ape genomes. To our knowledge, no further information has been published on other mammal species. Here, we have cloned the full-length alpha1A subunit in a non-primate species, the cow. The results have made it possible to explore the exon organization of the bovine CACNA1A gene as well as the splice alpha1A isoforms expressed by bovine chromaffin cells. We found a splice variant of the protein that, as in humans, also contains a polymorphic poly(Q) tract. Based on this result and using data from different Genome Databases, we performed an interspecies comparison of exon 47 and discovered that the poly(Q) tract is present in all the species studied, with the exception of primitive fish and rodents. Our results provide insight into the evolution of the CAG repeat tract at the C-terminus coding region of the CACNA1A gene.
Collapse
Affiliation(s)
- Eva Andrés-Mateos
- Departamento de Farmacología y Terapéutica, Facultad de Medicina, Universidad Autónoma de Madrid, Arzobispo Morcillo 4, 28029-Madrid, Spain
| | | | | | | | | | | | | |
Collapse
|
32
|
Kordasiewicz HB, Thompson RM, Clark HB, Gomez CM. C-termini of P/Q-type Ca2+ channel alpha1A subunits translocate to nuclei and promote polyglutamine-mediated toxicity. Hum Mol Genet 2006; 15:1587-99. [PMID: 16595610 DOI: 10.1093/hmg/ddl080] [Citation(s) in RCA: 105] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
P/Q-type voltage-gated calcium channels are regulated, in part, through the cytoplasmic C-terminus of their alpha1A subunit. Genetic absence or alteration of the C-terminus leads to abnormal channel function and neurological disease. Here, we show that the terminal 60-75 kDa of the endogenous alpha1A C-terminus is cleaved from the full-length protein and is present in cell nuclei. Antiserum to the C-terminus (CT-2) labels both wild-type mouse and human Purkinje cell nuclei, but not leaner mouse cerebellum. Human embryonic kidney cells stably expressing beta3 and alpha2delta subunits and transiently transfected with full-length human alpha1A contain a 75 kDa CT-2 reactive peptide in their nuclear fraction. Primary granule cells transfected with C-terminally Green fluorescent protein (GFP)-tagged alpha1A exhibit GFP nuclear labeling. Nuclear translocation depends partly on the presence of three nuclear localization signals within the C-terminus. The C-terminal fragment bears a polyglutamine tract which, when expanded (Q33) as in spinocerebellar ataxia type 6 (SCA6), is toxic to cells. Moreover, polyglutamine-mediated toxicity is dependent on nuclear localization. Finally, in the absence of flanking sequence, the Q33 expansion alone does not kill cells. These results suggest a novel processing of the P/Q-type calcium channel and a potential mechanism for the pathogenesis of SCA6.
Collapse
Affiliation(s)
- Holly B Kordasiewicz
- Department of Neuroscience, Unviersity of Minnesota, 420 Delaware Street SE, Minneapolis, 55455, USA
| | | | | | | |
Collapse
|
33
|
Kanumilli S, Tringham EW, Payne CE, Dupere JRB, Venkateswarlu K, Usowicz MM. Alternative splicing generates a smaller assortment of CaV2.1 transcripts in cerebellar Purkinje cells than in the cerebellum. Physiol Genomics 2005; 24:86-96. [PMID: 16278278 DOI: 10.1152/physiolgenomics.00149.2005] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
P/Q-type calcium channels control many calcium-driven functions in the brain. The CACNA1A gene encoding the pore-forming CaV2.1 (alpha1A) subunit of P/Q-type channels undergoes alternative splicing at multiple loci. This results in channel variants with different phenotypes. However, the combinatorial patterns of alternative splice events at two or more loci, and hence the diversity of CaV2.1 transcripts, are incompletely defined for specific brain regions and types of brain neurons. Using RT-PCR and splice variant-specific primers, we have identified multiple CaV2.1 transcript variants defined by different pairs of splice events in the cerebellum of adult rat. We have uncovered new splice variations between exons 28 and 34 (some of which predict a premature stop codon) and a new variation in exon 47 (which predicts a novel extended COOH-terminus). Single cell RT-PCR reveals that each individual cerebellar Purkinje neuron also expresses multiple alternative CaV2.1 transcripts, but the assortment is smaller than in the cerebellum. Two of these variants encode different extended COOH-termini which are not the same as those previously reported in Purkinje cells of the mouse. Our patch-clamp recordings show that calcium channel currents in the soma and dendrites of Purkinje cells are largely inhibited by a concentration of omega-agatoxin IVA selective for P-type over Q-type channels, suggesting that the different transcripts may form phenotypic variants of P-type calcium channels in Purkinje cells. These results expand the known diversity of CaV2.1 transcripts in cerebellar Purkinje cells, and propose the selective expression of distinct assortments of CaV2.1 transcripts in different brain neurons and species.
Collapse
|
34
|
Andrés-Mateos E, Renart J, Cruces J, Solís-Garrido LM, Serantes R, de Lucas-Cerrillo AM, Aldea M, García AG, Montiel C. Dynamic association of the Ca2+channel α1Asubunit and SNAP-25 in round or neurite-emitting chromaffin cells. Eur J Neurosci 2005; 22:2187-98. [PMID: 16262657 DOI: 10.1111/j.1460-9568.2005.04385.x] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Although the specific interaction between synaptic protein SNAP-25 and the alpha1A subunit of the Cav2.1 channels, which conduct P/Q-type Ca2+ currents, has been confirmed in in vitro-translated proteins and brain membrane studies, the question of how native proteins can establish this association in situ in developing neurons remains to be elucidated. Here we report data regarding this interaction in bovine chromaffin cells natively expressing both proteins. The two carboxyl-terminal splice variants of the alpha1A subunit identified in these cells share a synaptic protein interaction ('synprint') site within the II/III loop segment and are immunodetected by a specific antibody against bovine alpha1A protein. Moreover, both alpha1A isoforms form part of the P/Q-channels-SNARE complexes in situ because they are coimmunoprecipitated from solubilized chromaffin cell membranes by a monoclonal SNAP-25 antibody. The distribution of alpha1A and SNAP-25 was studied in round or transdifferentiated chromaffin cells using confocal microscopy and specific antibodies: the two proteins are colocalized at the cell body membrane in both natural cell types. However, during the first stages of the cell transdifferentiation process, SNAP-25 migrates alone out to the developing growth cone and what will become the nerve endings and varicosities of the mature neurites; alpha1A follows and colocalizes to SNAP-25 in the now mature processes. These observations lead us to propose that the association between SNAP-25 and alpha1A during neuritogenesis might promote not only the efficient coupling of the exocytotic machinery but also the correct insertion of P/Q-type channels at specialized active zones in presynaptic neuronal terminals.
Collapse
Affiliation(s)
- Eva Andrés-Mateos
- Departamento de Farmacología y Terapéutica, Facultad de Medicina, Universidad Autónoma de Madrid, Arzobispo Morcillo 4, 28029 Madrid, Spain
| | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Ishikawa K, Toru S, Tsunemi T, Li M, Kobayashi K, Yokota T, Amino T, Owada K, Fujigasaki H, Sakamoto M, Tomimitsu H, Takashima M, Kumagai J, Noguchi Y, Kawashima Y, Ohkoshi N, Ishida G, Gomyoda M, Yoshida M, Hashizume Y, Saito Y, Murayama S, Yamanouchi H, Mizutani T, Kondo I, Toda T, Mizusawa H. An autosomal dominant cerebellar ataxia linked to chromosome 16q22.1 is associated with a single-nucleotide substitution in the 5' untranslated region of the gene encoding a protein with spectrin repeat and Rho guanine-nucleotide exchange-factor domains. Am J Hum Genet 2005; 77:280-96. [PMID: 16001362 PMCID: PMC1224530 DOI: 10.1086/432518] [Citation(s) in RCA: 105] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2005] [Accepted: 06/03/2005] [Indexed: 12/11/2022] Open
Abstract
Autosomal dominant cerebellar ataxia (ADCA) is a group of heterogeneous neurodegenerative disorders. By positional cloning, we have identified the gene strongly associated with a form of degenerative ataxia (chromosome 16q22.1-linked ADCA) that clinically shows progressive pure cerebellar ataxia. Detailed examination by use of audiogram suggested that sensorineural hearing impairment may be associated with ataxia in our families. After restricting the candidate region in chromosome 16q22.1 by haplotype analysis, we found that all patients from 52 unrelated Japanese families harbor a heterozygous C-->T single-nucleotide substitution, 16 nt upstream of the putative translation initiation site of the gene for a hypothetical protein DKFZP434I216, which we have called "puratrophin-1" (Purkinje cell atrophy associated protein-1). The full-length puratrophin-1 mRNA had an open reading frame of 3,576 nt, predicted to contain important domains, including the spectrin repeat and the guanine-nucleotide exchange factor (GEF) for Rho GTPases, followed by the Dbl-homologous domain, which indicates the role of puratrophin-1 in intracellular signaling and actin dynamics at the Golgi apparatus. Puratrophin-1--normally expressed in a wide range of cells, including epithelial hair cells in the cochlea--was aggregated in Purkinje cells of the chromosome 16q22.1-linked ADCA brains. Consistent with the protein prediction data of puratrophin-1, the Golgi-apparatus membrane protein and spectrin also formed aggregates in Purkinje cells. The present study highlights the importance of the 5' untranslated region (UTR) in identification of genes of human disease, suggests that a single-nucleotide substitution in the 5' UTR could be associated with protein aggregation, and indicates that the GEF protein is associated with cerebellar degeneration in humans.
Collapse
Affiliation(s)
- Kinya Ishikawa
- Departments of Neurology and Neurological Science, Pathology, and Audiovestibular Science, Graduate School, and The 21st Century Center of Excellence Program on Brain Integration and Its Disorders, Tokyo Medical and Dental University, Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Department of Neurology, Tokyo Metropolitan Geriatric Hospital, and Department of Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo; Division of Functional Genomics, Department of Post-Genomics and Diseases, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan; Departments of Neurology and Clinical Laboratory, National Matsue Hospital, Matsue, Japan; Department of Neuropathology, Institute of Medical Science of Aging, Aichi Medical University, Aichi, Japan; and Department of Medical Genetics, Ehime University School of Medicine, Ehime, Japan
| | - Shuta Toru
- Departments of Neurology and Neurological Science, Pathology, and Audiovestibular Science, Graduate School, and The 21st Century Center of Excellence Program on Brain Integration and Its Disorders, Tokyo Medical and Dental University, Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Department of Neurology, Tokyo Metropolitan Geriatric Hospital, and Department of Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo; Division of Functional Genomics, Department of Post-Genomics and Diseases, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan; Departments of Neurology and Clinical Laboratory, National Matsue Hospital, Matsue, Japan; Department of Neuropathology, Institute of Medical Science of Aging, Aichi Medical University, Aichi, Japan; and Department of Medical Genetics, Ehime University School of Medicine, Ehime, Japan
| | - Taiji Tsunemi
- Departments of Neurology and Neurological Science, Pathology, and Audiovestibular Science, Graduate School, and The 21st Century Center of Excellence Program on Brain Integration and Its Disorders, Tokyo Medical and Dental University, Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Department of Neurology, Tokyo Metropolitan Geriatric Hospital, and Department of Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo; Division of Functional Genomics, Department of Post-Genomics and Diseases, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan; Departments of Neurology and Clinical Laboratory, National Matsue Hospital, Matsue, Japan; Department of Neuropathology, Institute of Medical Science of Aging, Aichi Medical University, Aichi, Japan; and Department of Medical Genetics, Ehime University School of Medicine, Ehime, Japan
| | - Mingshun Li
- Departments of Neurology and Neurological Science, Pathology, and Audiovestibular Science, Graduate School, and The 21st Century Center of Excellence Program on Brain Integration and Its Disorders, Tokyo Medical and Dental University, Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Department of Neurology, Tokyo Metropolitan Geriatric Hospital, and Department of Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo; Division of Functional Genomics, Department of Post-Genomics and Diseases, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan; Departments of Neurology and Clinical Laboratory, National Matsue Hospital, Matsue, Japan; Department of Neuropathology, Institute of Medical Science of Aging, Aichi Medical University, Aichi, Japan; and Department of Medical Genetics, Ehime University School of Medicine, Ehime, Japan
| | - Kazuhiro Kobayashi
- Departments of Neurology and Neurological Science, Pathology, and Audiovestibular Science, Graduate School, and The 21st Century Center of Excellence Program on Brain Integration and Its Disorders, Tokyo Medical and Dental University, Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Department of Neurology, Tokyo Metropolitan Geriatric Hospital, and Department of Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo; Division of Functional Genomics, Department of Post-Genomics and Diseases, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan; Departments of Neurology and Clinical Laboratory, National Matsue Hospital, Matsue, Japan; Department of Neuropathology, Institute of Medical Science of Aging, Aichi Medical University, Aichi, Japan; and Department of Medical Genetics, Ehime University School of Medicine, Ehime, Japan
| | - Takanori Yokota
- Departments of Neurology and Neurological Science, Pathology, and Audiovestibular Science, Graduate School, and The 21st Century Center of Excellence Program on Brain Integration and Its Disorders, Tokyo Medical and Dental University, Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Department of Neurology, Tokyo Metropolitan Geriatric Hospital, and Department of Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo; Division of Functional Genomics, Department of Post-Genomics and Diseases, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan; Departments of Neurology and Clinical Laboratory, National Matsue Hospital, Matsue, Japan; Department of Neuropathology, Institute of Medical Science of Aging, Aichi Medical University, Aichi, Japan; and Department of Medical Genetics, Ehime University School of Medicine, Ehime, Japan
| | - Takeshi Amino
- Departments of Neurology and Neurological Science, Pathology, and Audiovestibular Science, Graduate School, and The 21st Century Center of Excellence Program on Brain Integration and Its Disorders, Tokyo Medical and Dental University, Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Department of Neurology, Tokyo Metropolitan Geriatric Hospital, and Department of Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo; Division of Functional Genomics, Department of Post-Genomics and Diseases, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan; Departments of Neurology and Clinical Laboratory, National Matsue Hospital, Matsue, Japan; Department of Neuropathology, Institute of Medical Science of Aging, Aichi Medical University, Aichi, Japan; and Department of Medical Genetics, Ehime University School of Medicine, Ehime, Japan
| | - Kiyoshi Owada
- Departments of Neurology and Neurological Science, Pathology, and Audiovestibular Science, Graduate School, and The 21st Century Center of Excellence Program on Brain Integration and Its Disorders, Tokyo Medical and Dental University, Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Department of Neurology, Tokyo Metropolitan Geriatric Hospital, and Department of Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo; Division of Functional Genomics, Department of Post-Genomics and Diseases, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan; Departments of Neurology and Clinical Laboratory, National Matsue Hospital, Matsue, Japan; Department of Neuropathology, Institute of Medical Science of Aging, Aichi Medical University, Aichi, Japan; and Department of Medical Genetics, Ehime University School of Medicine, Ehime, Japan
| | - Hiroto Fujigasaki
- Departments of Neurology and Neurological Science, Pathology, and Audiovestibular Science, Graduate School, and The 21st Century Center of Excellence Program on Brain Integration and Its Disorders, Tokyo Medical and Dental University, Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Department of Neurology, Tokyo Metropolitan Geriatric Hospital, and Department of Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo; Division of Functional Genomics, Department of Post-Genomics and Diseases, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan; Departments of Neurology and Clinical Laboratory, National Matsue Hospital, Matsue, Japan; Department of Neuropathology, Institute of Medical Science of Aging, Aichi Medical University, Aichi, Japan; and Department of Medical Genetics, Ehime University School of Medicine, Ehime, Japan
| | - Masaki Sakamoto
- Departments of Neurology and Neurological Science, Pathology, and Audiovestibular Science, Graduate School, and The 21st Century Center of Excellence Program on Brain Integration and Its Disorders, Tokyo Medical and Dental University, Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Department of Neurology, Tokyo Metropolitan Geriatric Hospital, and Department of Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo; Division of Functional Genomics, Department of Post-Genomics and Diseases, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan; Departments of Neurology and Clinical Laboratory, National Matsue Hospital, Matsue, Japan; Department of Neuropathology, Institute of Medical Science of Aging, Aichi Medical University, Aichi, Japan; and Department of Medical Genetics, Ehime University School of Medicine, Ehime, Japan
| | - Hiroyuki Tomimitsu
- Departments of Neurology and Neurological Science, Pathology, and Audiovestibular Science, Graduate School, and The 21st Century Center of Excellence Program on Brain Integration and Its Disorders, Tokyo Medical and Dental University, Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Department of Neurology, Tokyo Metropolitan Geriatric Hospital, and Department of Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo; Division of Functional Genomics, Department of Post-Genomics and Diseases, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan; Departments of Neurology and Clinical Laboratory, National Matsue Hospital, Matsue, Japan; Department of Neuropathology, Institute of Medical Science of Aging, Aichi Medical University, Aichi, Japan; and Department of Medical Genetics, Ehime University School of Medicine, Ehime, Japan
| | - Minoru Takashima
- Departments of Neurology and Neurological Science, Pathology, and Audiovestibular Science, Graduate School, and The 21st Century Center of Excellence Program on Brain Integration and Its Disorders, Tokyo Medical and Dental University, Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Department of Neurology, Tokyo Metropolitan Geriatric Hospital, and Department of Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo; Division of Functional Genomics, Department of Post-Genomics and Diseases, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan; Departments of Neurology and Clinical Laboratory, National Matsue Hospital, Matsue, Japan; Department of Neuropathology, Institute of Medical Science of Aging, Aichi Medical University, Aichi, Japan; and Department of Medical Genetics, Ehime University School of Medicine, Ehime, Japan
| | - Jiro Kumagai
- Departments of Neurology and Neurological Science, Pathology, and Audiovestibular Science, Graduate School, and The 21st Century Center of Excellence Program on Brain Integration and Its Disorders, Tokyo Medical and Dental University, Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Department of Neurology, Tokyo Metropolitan Geriatric Hospital, and Department of Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo; Division of Functional Genomics, Department of Post-Genomics and Diseases, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan; Departments of Neurology and Clinical Laboratory, National Matsue Hospital, Matsue, Japan; Department of Neuropathology, Institute of Medical Science of Aging, Aichi Medical University, Aichi, Japan; and Department of Medical Genetics, Ehime University School of Medicine, Ehime, Japan
| | - Yoshihiro Noguchi
- Departments of Neurology and Neurological Science, Pathology, and Audiovestibular Science, Graduate School, and The 21st Century Center of Excellence Program on Brain Integration and Its Disorders, Tokyo Medical and Dental University, Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Department of Neurology, Tokyo Metropolitan Geriatric Hospital, and Department of Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo; Division of Functional Genomics, Department of Post-Genomics and Diseases, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan; Departments of Neurology and Clinical Laboratory, National Matsue Hospital, Matsue, Japan; Department of Neuropathology, Institute of Medical Science of Aging, Aichi Medical University, Aichi, Japan; and Department of Medical Genetics, Ehime University School of Medicine, Ehime, Japan
| | - Yoshiyuki Kawashima
- Departments of Neurology and Neurological Science, Pathology, and Audiovestibular Science, Graduate School, and The 21st Century Center of Excellence Program on Brain Integration and Its Disorders, Tokyo Medical and Dental University, Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Department of Neurology, Tokyo Metropolitan Geriatric Hospital, and Department of Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo; Division of Functional Genomics, Department of Post-Genomics and Diseases, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan; Departments of Neurology and Clinical Laboratory, National Matsue Hospital, Matsue, Japan; Department of Neuropathology, Institute of Medical Science of Aging, Aichi Medical University, Aichi, Japan; and Department of Medical Genetics, Ehime University School of Medicine, Ehime, Japan
| | - Norio Ohkoshi
- Departments of Neurology and Neurological Science, Pathology, and Audiovestibular Science, Graduate School, and The 21st Century Center of Excellence Program on Brain Integration and Its Disorders, Tokyo Medical and Dental University, Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Department of Neurology, Tokyo Metropolitan Geriatric Hospital, and Department of Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo; Division of Functional Genomics, Department of Post-Genomics and Diseases, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan; Departments of Neurology and Clinical Laboratory, National Matsue Hospital, Matsue, Japan; Department of Neuropathology, Institute of Medical Science of Aging, Aichi Medical University, Aichi, Japan; and Department of Medical Genetics, Ehime University School of Medicine, Ehime, Japan
| | - Gen Ishida
- Departments of Neurology and Neurological Science, Pathology, and Audiovestibular Science, Graduate School, and The 21st Century Center of Excellence Program on Brain Integration and Its Disorders, Tokyo Medical and Dental University, Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Department of Neurology, Tokyo Metropolitan Geriatric Hospital, and Department of Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo; Division of Functional Genomics, Department of Post-Genomics and Diseases, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan; Departments of Neurology and Clinical Laboratory, National Matsue Hospital, Matsue, Japan; Department of Neuropathology, Institute of Medical Science of Aging, Aichi Medical University, Aichi, Japan; and Department of Medical Genetics, Ehime University School of Medicine, Ehime, Japan
| | - Manabu Gomyoda
- Departments of Neurology and Neurological Science, Pathology, and Audiovestibular Science, Graduate School, and The 21st Century Center of Excellence Program on Brain Integration and Its Disorders, Tokyo Medical and Dental University, Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Department of Neurology, Tokyo Metropolitan Geriatric Hospital, and Department of Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo; Division of Functional Genomics, Department of Post-Genomics and Diseases, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan; Departments of Neurology and Clinical Laboratory, National Matsue Hospital, Matsue, Japan; Department of Neuropathology, Institute of Medical Science of Aging, Aichi Medical University, Aichi, Japan; and Department of Medical Genetics, Ehime University School of Medicine, Ehime, Japan
| | - Mari Yoshida
- Departments of Neurology and Neurological Science, Pathology, and Audiovestibular Science, Graduate School, and The 21st Century Center of Excellence Program on Brain Integration and Its Disorders, Tokyo Medical and Dental University, Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Department of Neurology, Tokyo Metropolitan Geriatric Hospital, and Department of Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo; Division of Functional Genomics, Department of Post-Genomics and Diseases, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan; Departments of Neurology and Clinical Laboratory, National Matsue Hospital, Matsue, Japan; Department of Neuropathology, Institute of Medical Science of Aging, Aichi Medical University, Aichi, Japan; and Department of Medical Genetics, Ehime University School of Medicine, Ehime, Japan
| | - Yoshio Hashizume
- Departments of Neurology and Neurological Science, Pathology, and Audiovestibular Science, Graduate School, and The 21st Century Center of Excellence Program on Brain Integration and Its Disorders, Tokyo Medical and Dental University, Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Department of Neurology, Tokyo Metropolitan Geriatric Hospital, and Department of Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo; Division of Functional Genomics, Department of Post-Genomics and Diseases, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan; Departments of Neurology and Clinical Laboratory, National Matsue Hospital, Matsue, Japan; Department of Neuropathology, Institute of Medical Science of Aging, Aichi Medical University, Aichi, Japan; and Department of Medical Genetics, Ehime University School of Medicine, Ehime, Japan
| | - Yuko Saito
- Departments of Neurology and Neurological Science, Pathology, and Audiovestibular Science, Graduate School, and The 21st Century Center of Excellence Program on Brain Integration and Its Disorders, Tokyo Medical and Dental University, Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Department of Neurology, Tokyo Metropolitan Geriatric Hospital, and Department of Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo; Division of Functional Genomics, Department of Post-Genomics and Diseases, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan; Departments of Neurology and Clinical Laboratory, National Matsue Hospital, Matsue, Japan; Department of Neuropathology, Institute of Medical Science of Aging, Aichi Medical University, Aichi, Japan; and Department of Medical Genetics, Ehime University School of Medicine, Ehime, Japan
| | - Shigeo Murayama
- Departments of Neurology and Neurological Science, Pathology, and Audiovestibular Science, Graduate School, and The 21st Century Center of Excellence Program on Brain Integration and Its Disorders, Tokyo Medical and Dental University, Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Department of Neurology, Tokyo Metropolitan Geriatric Hospital, and Department of Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo; Division of Functional Genomics, Department of Post-Genomics and Diseases, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan; Departments of Neurology and Clinical Laboratory, National Matsue Hospital, Matsue, Japan; Department of Neuropathology, Institute of Medical Science of Aging, Aichi Medical University, Aichi, Japan; and Department of Medical Genetics, Ehime University School of Medicine, Ehime, Japan
| | - Hiroshi Yamanouchi
- Departments of Neurology and Neurological Science, Pathology, and Audiovestibular Science, Graduate School, and The 21st Century Center of Excellence Program on Brain Integration and Its Disorders, Tokyo Medical and Dental University, Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Department of Neurology, Tokyo Metropolitan Geriatric Hospital, and Department of Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo; Division of Functional Genomics, Department of Post-Genomics and Diseases, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan; Departments of Neurology and Clinical Laboratory, National Matsue Hospital, Matsue, Japan; Department of Neuropathology, Institute of Medical Science of Aging, Aichi Medical University, Aichi, Japan; and Department of Medical Genetics, Ehime University School of Medicine, Ehime, Japan
| | - Toshio Mizutani
- Departments of Neurology and Neurological Science, Pathology, and Audiovestibular Science, Graduate School, and The 21st Century Center of Excellence Program on Brain Integration and Its Disorders, Tokyo Medical and Dental University, Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Department of Neurology, Tokyo Metropolitan Geriatric Hospital, and Department of Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo; Division of Functional Genomics, Department of Post-Genomics and Diseases, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan; Departments of Neurology and Clinical Laboratory, National Matsue Hospital, Matsue, Japan; Department of Neuropathology, Institute of Medical Science of Aging, Aichi Medical University, Aichi, Japan; and Department of Medical Genetics, Ehime University School of Medicine, Ehime, Japan
| | - Ikuko Kondo
- Departments of Neurology and Neurological Science, Pathology, and Audiovestibular Science, Graduate School, and The 21st Century Center of Excellence Program on Brain Integration and Its Disorders, Tokyo Medical and Dental University, Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Department of Neurology, Tokyo Metropolitan Geriatric Hospital, and Department of Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo; Division of Functional Genomics, Department of Post-Genomics and Diseases, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan; Departments of Neurology and Clinical Laboratory, National Matsue Hospital, Matsue, Japan; Department of Neuropathology, Institute of Medical Science of Aging, Aichi Medical University, Aichi, Japan; and Department of Medical Genetics, Ehime University School of Medicine, Ehime, Japan
| | - Tatsushi Toda
- Departments of Neurology and Neurological Science, Pathology, and Audiovestibular Science, Graduate School, and The 21st Century Center of Excellence Program on Brain Integration and Its Disorders, Tokyo Medical and Dental University, Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Department of Neurology, Tokyo Metropolitan Geriatric Hospital, and Department of Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo; Division of Functional Genomics, Department of Post-Genomics and Diseases, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan; Departments of Neurology and Clinical Laboratory, National Matsue Hospital, Matsue, Japan; Department of Neuropathology, Institute of Medical Science of Aging, Aichi Medical University, Aichi, Japan; and Department of Medical Genetics, Ehime University School of Medicine, Ehime, Japan
| | - Hidehiro Mizusawa
- Departments of Neurology and Neurological Science, Pathology, and Audiovestibular Science, Graduate School, and The 21st Century Center of Excellence Program on Brain Integration and Its Disorders, Tokyo Medical and Dental University, Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Department of Neurology, Tokyo Metropolitan Geriatric Hospital, and Department of Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo; Division of Functional Genomics, Department of Post-Genomics and Diseases, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan; Departments of Neurology and Clinical Laboratory, National Matsue Hospital, Matsue, Japan; Department of Neuropathology, Institute of Medical Science of Aging, Aichi Medical University, Aichi, Japan; and Department of Medical Genetics, Ehime University School of Medicine, Ehime, Japan
| |
Collapse
|
36
|
Luvisetto S, Fellin T, Spagnolo M, Hivert B, Brust PF, Harpold MM, Stauderman KA, Williams ME, Pietrobon D. Modal gating of human CaV2.1 (P/Q-type) calcium channels: I. The slow and the fast gating modes and their modulation by beta subunits. ACTA ACUST UNITED AC 2005; 124:445-61. [PMID: 15504896 PMCID: PMC2234000 DOI: 10.1085/jgp.200409034] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
The single channel gating properties of human CaV2.1 (P/Q-type) calcium channels and their modulation by the auxiliary β1b, β2e, β3a, and β4a subunits were investigated with cell-attached patch-clamp recordings on HEK293 cells stably expressing human CaV2.1 channels. These calcium channels showed a complex modal gating, which is described in this and the following paper (Fellin, T., S. Luvisetto, M. Spagnolo, and D. Pietrobon. 2004. J. Gen. Physiol. 124:463–474). Here, we report the characterization of two modes of gating of human CaV2.1 channels, the slow mode and the fast mode. A channel in the two gating modes differs in mean closed times and latency to first opening (both longer in the slow mode), in voltage dependence of the open probability (larger depolarizations are necessary to open the channel in the slow mode), in kinetics of inactivation (slower in the slow mode), and voltage dependence of steady-state inactivation (occurring at less negative voltages in the slow mode). CaV2.1 channels containing any of the four β subtypes can gate in either the slow or the fast mode, with only minor differences in the rate constants of the transitions between closed and open states within each mode. In both modes, CaV2.1 channels display different rates of inactivation and different steady-state inactivation depending on the β subtype. The type of β subunit also modulates the relative occurrence of the slow and the fast gating mode of CaV2.1 channels; β3a promotes the fast mode, whereas β4a promotes the slow mode. The prevailing mode of gating of CaV2.1 channels lacking a β subunit is a gating mode in which the channel shows shorter mean open times, longer mean closed times, longer first latency, a much larger fraction of nulls, and activates at more positive voltages than in either the fast or slow mode.
Collapse
Affiliation(s)
- Siro Luvisetto
- Dept. of Biomedical Sciences, University of Padova, Viale G. Colombo 3, 35121 Padova, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Kinoshita-Kawada M, Oberdick J, Xi Zhu M. A Purkinje cell specific GoLoco domain protein, L7/Pcp-2, modulates receptor-mediated inhibition of Cav2.1 Ca2+ channels in a dose-dependent manner. ACTA ACUST UNITED AC 2005; 132:73-86. [PMID: 15548431 DOI: 10.1016/j.molbrainres.2004.09.007] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/08/2004] [Indexed: 10/26/2022]
Abstract
L7/Pcp-2 is a GoLoco domain protein encoded by a Purkinje cell dendritic mRNA. Although biochemical interactions of GoLoco proteins with Galpha(o) and Galpha(i) are well documented, little is known about effector function modulation resulting from these interactions. The P-type Ca2+ channels might be physiological effectors of L7 because (1) they are the major voltage-dependent Ca2+ channels (VDCC) that modulate Purkinje cell output and (2) they are regulated by G(i/o) proteins. As a first step towards validating this hypothesis and to further understand the possible physiological effect of L7 protein and its two isoforms, we have coexpressed Ca(v)2.1 channels and kappa-opioid receptors (KORs) with varying amounts of L7A or L7B in Xenopus oocytes and measured ionic currents by two-electrode voltage clamping. Without receptor activation L7 did not alter the Ca2+ channel activity. With tonic and weak activation of the receptors, however, the Ca2+ channels were inhibited by 40-50%. This inhibition was enhanced by low, but dampened by high, expression levels of L7A and L7B and differences were observed between the two isoforms. The enhancing effect of L7 was occluded by overexpression of Gbetagamma, whereas the disinhibition was antagonized by overexpression of Galpha(o). We propose that L7 differentially affects the Galpha and Gbetagamma arms of receptor-induced G(i/o) signaling in a concentration-dependent manner, through which it increases the dynamic range of regulation of P/Q-type Ca2+ channels by G(i/o) protein-coupled receptors. This provides a framework for designing further experiments to determine how dendritic local fluctuations in L7 protein levels might influence signal processing in Purkinje cells.
Collapse
MESH Headings
- Animals
- Calcium Channels, N-Type/genetics
- Calcium Channels, N-Type/metabolism
- Calcium Channels, P-Type/genetics
- Calcium Channels, P-Type/metabolism
- Cell Membrane/genetics
- Cell Membrane/metabolism
- Dendrites/metabolism
- Female
- GTP-Binding Protein alpha Subunits/genetics
- GTP-Binding Protein alpha Subunits/metabolism
- GTP-Binding Protein alpha Subunits, Gi-Go/genetics
- GTP-Binding Protein alpha Subunits, Gi-Go/metabolism
- GTP-Binding Protein beta Subunits/genetics
- GTP-Binding Protein beta Subunits/metabolism
- GTP-Binding Protein gamma Subunits/genetics
- GTP-Binding Protein gamma Subunits/metabolism
- Gene Dosage
- Membrane Potentials/genetics
- Nerve Tissue Proteins/genetics
- Nerve Tissue Proteins/metabolism
- Neural Inhibition/genetics
- Oocytes
- Patch-Clamp Techniques
- Protein Structure, Tertiary/genetics
- Purkinje Cells/metabolism
- Receptors, Cell Surface/genetics
- Receptors, Cell Surface/metabolism
- Receptors, Opioid, kappa/genetics
- Receptors, Opioid, kappa/metabolism
- Signal Transduction/genetics
- Xenopus laevis
Collapse
Affiliation(s)
- Mariko Kinoshita-Kawada
- Department of Neuroscience and the Center for Molecular Neurobiology, The Ohio State University, 168 Rightmire Hall, 1060 Carmack Road, Columbus, OH 43210, USA
| | | | | |
Collapse
|
38
|
Chaudhuri D, Chang SY, DeMaria CD, Alvania RS, Soong TW, Yue DT. Alternative splicing as a molecular switch for Ca2+/calmodulin-dependent facilitation of P/Q-type Ca2+ channels. J Neurosci 2004; 24:6334-42. [PMID: 15254089 PMCID: PMC6729554 DOI: 10.1523/jneurosci.1712-04.2004] [Citation(s) in RCA: 73] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Alternative splicing of the P/Q-type channel (Ca(V)2.1) promises customization of the computational repertoire of neurons. Here we report that concerted splicing of its main alpha1A subunit, at both an EF-hand-like domain and the channel C terminus, controls the form of Ca2+-dependent facilitation (CDF), an activity-dependent enhancement of channel opening that is triggered by calmodulin. In recombinant channels, such alternative splicing switches CDF among three modes: (1) completely "ON" and driven by local Ca2+ influx through individual channels, (2) completely "OFF," and (3) partially OFF but inducible by elevated global Ca2+ influx. Conversion from modes 1 to 3 represents an unprecedented dimension of control. The physiological function of these variants is likely important, because we find that the distribution of EF-hand splice variants is strikingly heterogeneous in the human brain, varying both across regions and during development.
Collapse
Affiliation(s)
- Dipayan Chaudhuri
- Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
| | | | | | | | | | | |
Collapse
|
39
|
Jurkat-Rott K, Lehmann-Horn F. The impact of splice isoforms on voltage-gated calcium channel alpha1 subunits. J Physiol 2003; 554:609-19. [PMID: 14645450 PMCID: PMC1664792 DOI: 10.1113/jphysiol.2003.052712] [Citation(s) in RCA: 47] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
Abstract
Semi-conserved exon boundaries in members of the CACNA1 gene family result in recurring pre-mRNA splicing patterns. The resulting variations in the encoded pore-forming subunit of the voltage-gated calcium channel affect functionally significant regions, such as the vicinity of the voltage-sensing S4 segments or the intracellular loops that are important for protein interaction. In addition to generating functional diversity, RNA splicing regulates the quantitative expression of other splice isoforms of the same gene by producing transcripts with premature stop codons which encode two-domain or three-domain channels. An overview of some of the known splice isoforms of the alpha(1) calcium channel subunits and their significance is given.
Collapse
|
40
|
Kaneko S. Alternative splicing of Cav2 genes and their functional significance. Nihon Yakurigaku Zasshi 2003; 121:233-40. [PMID: 12777842 DOI: 10.1254/fpj.121.233] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/20/2023]
Abstract
Alternative splicing is one of the most pharmacologically and physiologically significant mechanisms for the functional diversity of the mammalian genomes. Here I review recent results on the diversity of the Ca(v)2 subclass of voltage-dependent Ca(2+) channel gene in neurons. Although the entire picture of alternative splicing is not yet understood, emerging evidences suggest the Ca(v)2 isoforms permit optimization of Ca(2+) signaling in different regions of the brain with specific pharmacological ligands.
Collapse
Affiliation(s)
- Shuji Kaneko
- Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Japan.
| |
Collapse
|
41
|
Systematic identification of splice variants in human P/Q-type channel alpha1(2.1) subunits: implications for current density and Ca2+-dependent inactivation. J Neurosci 2002. [PMID: 12451115 DOI: 10.1523/jneurosci.22-23-10142.2002] [Citation(s) in RCA: 99] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
P/Q-type (Ca(v)2.1) calcium channels support a host of Ca2+-driven neuronal functions in the mammalian brain. Alternative splicing of the main alpha1A (alpha1(2.1)) subunit of these channels may thereby represent a rich strategy for tuning the functional profile of diverse neurobiological processes. Here, we applied a recently developed "transcript-scanning" method for systematic determination of splice variant transcripts of the human alpha1(2.1) gene. This screen identified seven loci of variation, which together have never been fully defined in humans. Genomic sequence analysis clarified the splicing mechanisms underlying the observed variation. Electrophysiological characterization and a novel analytical paradigm, termed strength-current analysis, revealed that one focus of variation, involving combinatorial inclusion and exclusion of exons 43 and 44, exerted a primary effect on current amplitude and a corollary effect on Ca2+-dependent channel inactivation. These findings significantly expand the anticipated scope of functional diversity produced by splice variation of P/Q-type channels.
Collapse
|
42
|
Lipscombe D, Pan JQ, Gray AC. Functional diversity in neuronal voltage-gated calcium channels by alternative splicing of Ca(v)alpha1. Mol Neurobiol 2002; 26:21-44. [PMID: 12392054 DOI: 10.1385/mn:26:1:021] [Citation(s) in RCA: 82] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Alternative splicing is a critical mechanism used extensively in the mammalian nervous system to increase the level of diversity that can be achieved by a set of genes. This review focuses on recent studies of voltage-gated calcium (Ca) channel Ca(v)alpha1 subunit splice isoforms in neurons. Voltage-gated Ca channels couple changes in neuronal activity to rapid changes in intracellular Ca levels that in turn regulate an astounding range of cellular processes. Only ten genes have been identified that encode Ca(v)alpha1 subunits, an insufficient number to account for the level of functional diversity among voltage-gated Ca channels. The consequences of regulated alternative splicing among the genes that comprise voltage-gated Ca channels permits specialization of channel function, optimizing Ca signaling in different regions of the brain and in different cellular compartments. Although the full extent of alternative splicing is not yet known for any of the major subtypes of voltage-gated Ca channels, it is already clear that it adds a rich layer of structural and functional diversity".
Collapse
Affiliation(s)
- Diane Lipscombe
- Department of Neuroscience, Brown University, Providence, RI 02912, USA.
| | | | | |
Collapse
|